Innovatus Capital Partners — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

JenaValvejenavalve.comAug 2022 · $100M

JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.

Digital HealthHealthtechMedical DevicesIrvine, US

Hans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)

Board Arnd Kaltofen(Director)inErik Amble(Director)

Co-investorsAndera Partners Bain Capital Life Sciences VI Partners Atlas Venture Gimv Legend Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.